Skip to main content
Clinical Trials/JPRN-UMIN000040157
JPRN-UMIN000040157
Not yet recruiting
未知

Prospective clinical study aiming at the improvement of hepatic encephalopathy and hepatic functional reserve of patients with liver cirrhosis by the secretory laxative agate lubiprostone - Improvement of hepatic encephalopathy and hepatic functional reserve by lubiprostone

ara Medical University Gastroenterology0 sites60 target enrollmentStarted: April 21, 2020Last updated:

Overview

Phase
未知
Status
Not yet recruiting
Sponsor
ara Medical University Gastroenterology
Enrollment
60

Overview

Brief Summary

No summary available.

Study Design

Study Type
Observational

Eligibility Criteria

Ages
20years-old to 80years-old (—)
Sex
All

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • 1\. \<\=19 y.o. or 81 y.o.\<\= 2\. pregnancy or breast\-feeding 3\. have ever taken lubiprostone 4\. heart failure (admission by 6 months) 5\. renal severe failure(eGFR\<30 ml/min/1\.73m2\) 6\. serum sodium \<125mEq/L or \>150mEq/L 7\. Cerebral infarction without paralysis and lacunar infarction 8\. Dementia more than Performance Status 2 9\. abdominal surgery career (stomach segmental resection or intestinal tract excision) 10\. with taking opioid agents 11\. change or increase diuretic agents for obserbation period 12\. with infectious disease or gastrointestinal breeding 13\. with malignant tumor 14\. patients of refusal this trial 15\. The patient who judged that this study responsibility doctor and allotment doctor were inadequate

Investigators

Sponsor
ara Medical University Gastroenterology

Similar Trials